Dopamine receptors and brain function

In the central nervous system (CNS), dopamine is involved in the control of locomotion, cognition, affect and neuroendocrine secretion. These actions of dopamine are mediated by five different receptor subtypes, which are members of the large G-protein coupled receptor superfamily. The dopamine receptor subtypes are divided into two major subclasses: the D1-like and D2-like receptors, which typically couple to Gs and Gj mediated transduction systems. In the CNS, the various receptor subtypes display specific anatomical distributions, with D1-like receptors being mainly post-synaptic and D2-like receptors being both pre- and post-synaptic. D1 and D2 dopamine receptors, the most abundant subtypes in the CNS, appear to be expressed largely in distinct neurons. Substance P and dynorphin, which are expressed in D1 receptor-containing neurons, as well as pre-proenkephalin in D2 receptor-containing neurons, have been used as monitors of dopaminergic activity in the CNS. Expression of immediate early genes, in particular fos, has also been found to correlate with dopaminergic transmission. Dopamine released from the hypothalamus controls the synthesis and secretion of prolactin from the anterior pituitary via D2 dopamine receptors. As yet none of the dopamine receptor subtypes have been associated with the etiology of psychotic disorders, such as schizophrenia. However, the recent characterization of D3 and D4 receptors which are, interestingly, expressed in areas of the CNS mediating cognition and affect or showing increased affinity for certain neuroleptics, have renewed the interest and hope of finding effective neuroleptics devoid of side effects. Finally, the recent production of genetically-derived animals lacking several of these receptor genes should help elucidate which specific physiological paradigms the receptors mediate.

[1]  L. Swanson,et al.  A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. , 1990, Annual review of physiology.

[2]  D. Segal,et al.  Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways , 1976, Brain Research.

[3]  J. Gusella Location cloning strategy for characterizing genetic defects in Huntington's disease and Alzheimer's disease , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  A. Surprenant,et al.  Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs. , 1991, The Journal of physiology.

[5]  R. Murray,et al.  Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. , 1994, American journal of medical genetics.

[6]  R. Rozmahel,et al.  Human dopamine D1 receptor encoded by an intronless gene on chromosome 5 , 1990, Nature.

[7]  J. Bolam,et al.  Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  S. Fuchs,et al.  A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. , 1993, The Journal of biological chemistry.

[9]  G. Giannattasio,et al.  Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. , 1981, Life sciences.

[10]  D. Sibley,et al.  Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors , 1984, Molecular and Cellular Endocrinology.

[11]  R. Iyengar,et al.  Specificity of receptor-G protein interactions. Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system. , 1990, The Journal of biological chemistry.

[12]  R. Todd,et al.  Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Meltzer Treatment of the neuroleptic-nonresponsive schizophrenic patient. , 1992, Schizophrenia bulletin.

[14]  J. Axelrod,et al.  A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Bloch,et al.  Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Biden,et al.  Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. , 1992, Molecular Endocrinology.

[17]  B. Bloch,et al.  D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.

[18]  D. M. Jackson,et al.  Dopamine receptors: molecular biology, biochemistry and behavioural aspects. , 1994, Pharmacology & therapeutics.

[19]  J. Vincent,et al.  Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. , 1990, Endocrinology.

[20]  S. Snyder,et al.  3H-Spiroperidol labels dopamine receptors in pituitary and brain. , 1977, European journal of pharmacology.

[21]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[22]  F. Sladeczek,et al.  Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. , 1986, The Journal of biological chemistry.

[23]  D. Barber,et al.  Multiple receptors coupled to adenylate cyclase regulate Na-H exchange independent of cAMP. , 1990, The Journal of biological chemistry.

[24]  Susan R. George,et al.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.

[25]  P. Seeman,et al.  Dopamine receptor pharmacology. , 1994, Trends in pharmacological sciences.

[26]  J. Kane,et al.  Towards More Effective Antipsychotic Treatment , 1994, British Journal of Psychiatry.

[27]  A. Graybiel,et al.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Watson,et al.  Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: A double in situ hybridization study , 1995, The Journal of comparative neurology.

[29]  M. Caron,et al.  Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Memo,et al.  Dopaminergic Inhibition of Prolactin Release and Calcium Influx Induced by Neurotensin in Anterior Pituitary Is Independent of Cyclic AMP System , 1986, Journal of neurochemistry.

[31]  M. Caron,et al.  Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. , 1978, The Journal of biological chemistry.

[32]  D. Grandy,et al.  Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Akil,et al.  Site-directed mutagenesis of the human dopamine D2 receptor. , 1992, European journal of pharmacology.

[34]  Bruno Giros,et al.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.

[35]  H. Meltzer,et al.  The mechanism of action of novel antipsychotic drugs. , 1991, Schizophrenia bulletin.

[36]  J. Kebabian,et al.  The Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland: Pharmacological Characterization , 1980 .

[37]  M. Caron,et al.  CHAPTER 13 – Structure and Function of Adrenergic Receptors: Models for Understanding G Protein-Coupled Receptors , 1990 .

[38]  G. Mcallister,et al.  Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells , 1992, FEBS letters.

[39]  E. Friedman,et al.  Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. , 1990, The Journal of pharmacology and experimental therapeutics.

[40]  G. Lahoste,et al.  Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Caron,et al.  Recent advances in the molecular biology of dopamine receptors. , 1993, Annual review of neuroscience.

[42]  Ming Xu,et al.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses , 1994, Cell.

[43]  A. Graybiel,et al.  D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  M. Martres,et al.  Effects of Dopaminergic Transmission Interruption on the D2 Receptor Isoforms in Various Cerebral Tissues , 1992, Journal of neurochemistry.

[45]  C. Felder,et al.  cAMP-independent, G protein-linked inhibition of Na+/H+ exchange in renal brush border by D1 dopamine agonists. , 1993, The American journal of physiology.

[46]  F. Post Creativity and Psychopathology a Study of 291 World-Famous Men , 1994, British Journal of Psychiatry.

[47]  H Philippe,et al.  An evolutionary view of drug-receptor interaction: the bioamine receptor family. , 1995, Trends in pharmacological sciences.

[48]  J. Dowling,et al.  Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[49]  E. Smeraldi,et al.  Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred. , 1994, Archives of general psychiatry.

[50]  W. Carpenter,et al.  Treatment of negative symptoms. , 1985, Schizophrenia bulletin.

[51]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Seeman,et al.  Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding. , 1993, Biochemical and biophysical research communications.

[53]  M. Knowles,et al.  Expression and pharmacological characterization of the human D3 dopamine receptor. , 1994, The Journal of pharmacology and experimental therapeutics.

[54]  M. Martres,et al.  Opposing Roles for Dopamine D2 and D3 Receptors on Neurotensin mRNA Expression in Nucleus Accumbens , 1994, The European journal of neuroscience.

[55]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[56]  D. Grandy,et al.  Distribution of D5 dopamine receptor mRNA in rat brain , 1992, Neuroscience Letters.

[57]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[58]  D. Grandy,et al.  Differential Sensitivity of the Short and Long Human Dopamine D2 Receptor Subtypes to Protein Kinase C , 1992, Journal of neurochemistry.

[59]  M. Rosenfeld,et al.  A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype , 1988, Cell.

[60]  M. Knowles,et al.  Pharmacology of high‐threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors , 1994, British journal of pharmacology.

[61]  M. Rosenfeld,et al.  Anterior pituitary development: Short tales from dwarf mice , 1992, Cell.

[62]  H. Niznik,et al.  D1A, D1B, and D1C dopamine receptors from Xenopus laevis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Todd,et al.  Dopamine D2 and D3 receptors inhibit dopamine release. , 1994, The Journal of pharmacology and experimental therapeutics.

[64]  D. Sibley,et al.  Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. , 1991, Molecular pharmacology.

[65]  P. Canonico,et al.  The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine. , 1983, Endocrinology.

[66]  M. Martres,et al.  Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism , 1991, Nature.

[67]  C. Maclean,et al.  Exclusion of linkage between schizophrenia and the D2 dopamine receptor gene region of chromosome 11q in 112 Irish multiplex families. , 1993, Archives of general psychiatry.

[68]  J. Bockaert,et al.  Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors. , 1992, Molecular endocrinology.

[69]  P. Albert,et al.  Cholera toxin-sensitive 3',5'-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A. , 1992, Molecular endocrinology.

[70]  R. Hershberger,et al.  Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. , 1992, The Journal of biological chemistry.

[71]  P. Seeman,et al.  Dopamine D4 receptors elevated in schizophrenia , 1993, Nature.

[72]  F. J. White,et al.  Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications , 1987 .

[73]  J. Vincent,et al.  Electrophysiological responses to dopamine of rat hypophysial cells in lactotroph‐enriched primary cultures. , 1987, The Journal of physiology.

[74]  P. Spano,et al.  Lack of coupling of D-2 receptors to adenylate cyclase in GH-3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes. , 1991, The Journal of biological chemistry.

[75]  H. Elsholtz,et al.  A Dopamine-responsive Domain in the N-terminal Sequence of Pit-1 , 1995, The Journal of Biological Chemistry.

[76]  D. Grandy,et al.  Cloning and expression of human and rat Dt dopamine receptors , 1990, Nature.

[77]  G. Mcallister,et al.  Depression of high‐threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108‐15 cells , 1994, British journal of pharmacology.

[78]  R. Todd,et al.  Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. , 1994, The Journal of pharmacology and experimental therapeutics.

[79]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[80]  M. Memo,et al.  Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs. , 1989, The Journal of physiology.

[81]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[82]  T. Branchek,et al.  Molecular cloning and characterization of a high affinity dopamine receptor (D1 beta) and its pseudogene. , 1991, The Journal of biological chemistry.

[83]  J. Slightom,et al.  D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[84]  J. Bockaert,et al.  Dual mechanisms of inhibition by dopamine of basal and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. Evidence for an inhibition not mediated by voltage-dependent Ca2+ channels. , 1990, The Journal of biological chemistry.

[85]  M. Caron,et al.  High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. , 1994, The Journal of biological chemistry.

[86]  P. Sokoloff,et al.  Novel dopamine receptors half a decade later. , 1995, Trends in pharmacological sciences.

[87]  E. Borrelli,et al.  Preferential coupling between dopamine D2 receptors and G-proteins. , 1993, Molecular endocrinology.

[88]  L. DeLisi,et al.  Linkage analysis between schizophrenia and a microsatellite polymorphism for the D5 dopamine receptor gene. , 1994, Psychiatric genetics.

[89]  P. Seeman,et al.  Dopamine D4‐Like Receptor Elevation in Schizophrenia: Cloned D2 and D4 Receptors Cannot Be Discriminated by Raclopride Competition Against [3H]Nemonapride , 1995, Journal of neurochemistry.

[90]  G S Oxford,et al.  D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[91]  S. Senogles The D2 dopamine receptor mediates inhibition of growth in GH4ZR7 cells: involvement of protein kinase-C epsilon. , 1994, Endocrinology.

[92]  P. Seeman Brain dopamine receptors. , 1980, Pharmacological reviews.

[93]  H. Niznik,et al.  The Dopamine D1D Receptor , 1995, The Journal of Biological Chemistry.

[94]  R. Fukuda,et al.  Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus. , 1994, American journal of medical genetics.

[95]  J. Ramsdell,et al.  Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix. , 1982, The Journal of clinical endocrinology and metabolism.

[96]  A. Levey,et al.  D1 and D2 dopamine receptor mRNA in rat brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[97]  M. Caron,et al.  Molecular cloning and expression of the gene for a human D1 dopamine receptor , 1990, Nature.

[98]  J. Meldolesi,et al.  Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in LtK- fibroblasts, hyperpolarization, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells. , 1990, The Journal of biological chemistry.

[99]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[100]  M. Caron,et al.  Purification and characterization of the D2-dopamine receptor from bovine anterior pituitary. , 1988, The Journal of biological chemistry.

[101]  B. Bloch,et al.  Anatomical study of enkephalin gene expression in the rat forebrain following haloperidol treatment , 1987, Neuroscience Letters.

[102]  Bruno Giros,et al.  Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.

[103]  J. Vincent,et al.  Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids. , 1991, Endocrinology.

[104]  Sigmundson Hk Pharmacotherapy of schizophrenia: a review. , 1994 .

[105]  K. Behnke,et al.  Sulpiride and Haloperidol in Schizophrenia: A Double-blind Cross-over Study of Therapeutic Effect, Side Effects and Plasma Concentrations , 1985, British Journal of Psychiatry.

[106]  P. Goldman-Rakic,et al.  Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[107]  H. V. Van Tol,et al.  Distribution of D2 dopamine receptor mRNA in rat brain. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[108]  D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations. , 1993, The Journal of pharmacology and experimental therapeutics.

[109]  M. Caron,et al.  Molecular characterization of the dopamine transporter. , 1993, Trends in pharmacological sciences.

[110]  R. Mackenzie,et al.  Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. , 1993, Molecular pharmacology.

[111]  R. Todd,et al.  The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. , 1992, The New biologist.

[112]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[113]  L. Chiodo,et al.  Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells. , 1993, Molecular pharmacology.

[114]  M. E. Lajiness,et al.  Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. , 1994, Molecular pharmacology.

[115]  Stephen J. Fink,et al.  Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons , 1993, Brain Research.

[116]  S. Matthysse Dopamine and the pharmacology of schizophrenia: the state of the evidence. , 1974, Journal of psychiatric research.

[117]  D. Sibley,et al.  D2 dopamine receptor localization on striatonigral neurons , 1992, Neuroscience Letters.

[118]  D. Grandy,et al.  Molecular biology of the dopamine receptors. , 1991, European journal of pharmacology.

[119]  P. Strange,et al.  Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells , 1985, Neuroscience Letters.

[120]  A. Sidhu,et al.  Coupling of Human D-1 Dopamine Receptors to Different Guanine Nucleotide Binding Proteins. EVIDENCE THAT D-1 DOPAMINE RECEPTORS CAN COUPLE TO BOTH Gs AND Go(*) , 1995, The Journal of Biological Chemistry.

[121]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[122]  B. Bloch,et al.  Reserpine treatment stimulates enkephalin and D2 dopamine receptor gene expression in the rat striatum. , 1992, Brain research. Molecular brain research.

[123]  D. Jackson,et al.  Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats , 1989, Brain Research.

[124]  H. Fibiger,et al.  Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine , 1992, Neuroscience.

[125]  Effect of reserpine treatment on enkephalin mRNA level in the rat striatum: an in situ hybridization study. , 1995, Brain research. Molecular brain research.

[126]  I. Nussinovitch,et al.  Dopamine inhibits voltage-activated calcium channel currents in rat pars intermedia pituitary cells , 1992, Brain Research.

[127]  K. Kidd,et al.  No linkage between D2 dopamine receptor gene region and schizophrenia. , 1991, Archives of general psychiatry.

[128]  K. Jakobs,et al.  G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells. , 1994, The Journal of biological chemistry.

[129]  D. Grandy,et al.  Differential Coupling of D1 and D5 Dopamine Receptors to Guanine Nucleotide Binding Proteins in Transfected GH4C1 Rat Somatomammotrophic Cells , 1995, Journal of neurochemistry.

[130]  B. Bunney,et al.  Mechanisms of action of atypical antipsychotic drugs Implications for novel therapeutic strategies for schizophrenia , 1991, Schizophrenia Research.

[131]  S. Tonegawa,et al.  Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice , 1994, Cell.

[132]  C. Gerfen,et al.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[133]  M. Martres,et al.  Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. , 1994, European journal of pharmacology.

[134]  M. Makman,et al.  Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[135]  E. Borrelli,et al.  Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[136]  B. Bloch,et al.  Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary. , 1994, Brain research. Molecular brain research.

[137]  J. Roberts,et al.  Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[138]  S. Hunt,et al.  Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland , 1982, Neuroscience Letters.

[139]  J. Meldolesi,et al.  Dopamine inhibits cytosolic Ca2+ increases in rat lactotroph cells. Evidence of a dual mechanism of action. , 1987, The Journal of biological chemistry.

[140]  C. Gerfen,et al.  Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[141]  R. Harlan,et al.  Morphine activation of c-fos expression in rat brain. , 1988, Biochemical and biophysical research communications.

[142]  P. Spano,et al.  Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. , 1978, Advances in biochemical psychopharmacology.

[143]  M. Caron,et al.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[144]  G. F. Hess,et al.  A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus , 1990, Nature.

[145]  B. Bloch,et al.  Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: A quantitative in situ hybridization study , 1991, Neuroscience.

[146]  M. Caron,et al.  Adrenergic receptors. Models for the study of receptors coupled to guanine nucleotide regulatory proteins. , 1988, The Journal of biological chemistry.

[147]  P. Albert,et al.  Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene. , 1991, The Journal of biological chemistry.

[148]  M. Martres,et al.  Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. , 1991, Biochemical and biophysical research communications.

[149]  J. Kemp,et al.  Functional expression of human D3 dopamine receptors in differentiated neuroblastoma × glioma NG108–15 cells , 1994, British journal of pharmacology.

[150]  J. C. Stoof,et al.  Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review. , 1982, Neuroendocrinology.

[151]  M. Caron,et al.  Chromosomal organization of adrenergic receptor genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[152]  P. Seeman,et al.  Multiple dopamine D4 receptor variants in the human population , 1992, Nature.

[153]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[154]  P. Seeman Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[155]  K. Neve,et al.  Dopamine D2 receptor stimulation of Na+/H+ exchange assessed by quantification of extracellular acidification. , 1992, The Journal of biological chemistry.

[156]  J. Waddington Functional interactions between D-1 and D-2 dopamine receptor systems: their role in the regulation of psychomotor behaviour, putative mechanisms, and clinical relevance , 1989, Journal of psychopharmacology.

[157]  R. Todd,et al.  Characterization of the human dopamine D3 receptor expressed in transfected cell lines. , 1994, European journal of pharmacology.

[158]  J. Bockaert,et al.  Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. , 1983, Molecular pharmacology.

[159]  M. Martres,et al.  Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain , 1995, Neuroscience.

[160]  R. Todd,et al.  Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[161]  G. Reynolds,et al.  Beyond the Dopamine Hypothesis , 1989, British Journal of Psychiatry.

[162]  M. Potenza,et al.  Functional expression and characterization of human D2 and D3 dopamine receptors , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[163]  B. Bloch,et al.  Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons , 1995, Neuroscience.

[164]  D. Surmeier,et al.  Dopamine receptor subtypes colocalize in rat striatonigral neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[165]  H. Robertson,et al.  Dopamine receptor interactions: some implications for the treatment of Parkinson's disease , 1992, Trends in Neurosciences.

[166]  C. Gerfen The neostriatal mosaic: multiple levels of compartmental organization , 1992, Trends in Neurosciences.

[167]  J. Cadet,et al.  Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine. , 1992, Brain research. Molecular brain research.

[168]  J. Vincent,et al.  Effects of dopamine on voltage-dependent potassium currents in identified rat lactotroph cells. , 1990, Neuroendocrinology.

[169]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[170]  R. Post,et al.  Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain , 1989, Brain Research.

[171]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[172]  B. Bloch,et al.  Expression of the d3 dopamine receptor in peptidergic neurons of the nucleus accumbens: Comparison with the D1 and D2 dopamine receptors , 1996, Neuroscience.

[173]  M. Caron,et al.  The human D1A dopamine receptor gene promoter directs expression of a reporter gene to the central nervous system in transgenic mice. , 1995, Brain research. Molecular brain research.

[174]  H. Coon,et al.  Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. , 1993, American journal of human genetics.

[175]  M. Knowles,et al.  Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. , 1995, Journal of Receptor and Signal Transduction Research.

[176]  M. Rosenfeld,et al.  Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. , 1988, Science.

[177]  J. Bockaert,et al.  Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cells , 1992, Neuron.

[178]  M. Memo,et al.  Activation of Dopamine D2 Receptors Linked to Voltage‐Sensitive Potassium Channels Reduces Forskolin‐Induced Cyclic AMP Formation in Rat Pituitary Cells , 1992, Journal of neurochemistry.

[179]  J. Laitinen Dopamine Stimulates K+ Efflux in the Chick Retina via D1 Receptors Independently of Adenylyl Cyclase Activation , 1993, Journal of neurochemistry.

[180]  H. Robertson Immediate-early genes, neuronal plasticity, and memory. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[181]  M. Scheideler,et al.  Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor. , 1994, European journal of pharmacology.

[182]  B. Bloch,et al.  Dopamine receptor gene expression by enkephalin neurons in rat forebrain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.